...III trials of hydroxychloroquine have been terminated. Four additional antiparasitic agents are being evaluated for COVID: ivermectin...

...which are repurposed, are leading the therapeutic classes, beating out antiparasitics such as hydroxychloroquine and ivermectin...

...5/8 Post $0.18 $0.28 -36% Genmab A/S (CSE:GEN; Pink:GMXAY) 5/8 Post NA DKK 3.20 NA Perrigo...

...nematodes that depend on Wolbachia , the parasites' endosymbiont, for survival. Approved therapies such as ivermectin...

...which could include a separation to shareholders, sale or merger -- to complete in 2H19. Perrigo...
...years. In June, FDA issued a letter to the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo...
...misbranding. Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO), Dublin, Ireland Business: Generics Jaime De Leon Merck & Co. Inc. Perrigo...

...FDA determined the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO) has...
...is notable in that regard, that they're following up and threatening to do something." Elizabeth S. Eaton Perrigo...

...officer. He was group VP and head of patient engagement at Shire plc (LSE:SHP; NASDAQ:SHPG). Perrigo...

...Basi CSO. He was chief science and technology officer at Elan Corp. plc , which Perrigo...

...Hasler will serve as Vicarius' CEO. He was COO at Elan Corp. plc , which Perrigo...

...Hasler will serve as Vicarius' CEO. He was COO at Elan Corp. plc , which Perrigo...